Back to search
Contrast Agent
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Contrast Agent trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Contrast Agent trials you may qualify forThis study aims to gain insights into aortic blood flow in healthy volunteers using PC 4D-flow MRI
Women with extremely dense breasts (nearly all glandular and connective tissue, little fatty tissue) have a 3-6 times higher risk of breast cancer than women wi…
This study aims to evaluate the feasibility of Laser Speckle Contrast Imaging for perioperative perfusion assessment of the lower extremity before, during, and…
The goal of this clinical trial is to compare distension quality and patient experience of water and polyethylene glycol preparation as oral contrast media in M…
Women at high risk of breast cancer (BC) should undergo annual magnetic resonance imaging (MRI) and digital mammography (DM) from at least ages 35 to 60. While…
This is a prospective, multicenter study designed to develop and validate a deep learning model for screening valvular heart diseases using routine, non-contras…
The purpose of this study is to evaluate the efficacy of HRS-9231 for Magnetic Resonance Imaging (MRI) of body regions excluding the Central Nervous System (CNS…
Calcification clusters are 30-40% of recalls in mammographic screening, but have a low positive predictive value (\~15%) for ductal cancer in situ (DCIS) or inv…